Which “Spiriva” patent is being asked about?
“Spiriva” is the brand name for tiotropium inhalation products, and patent questions usually hinge on which specific formulation/device you mean (for example, HandiHaler vs Respimat). The exact patent list, expiration timing, and any follow-on exclusivities vary by product and jurisdiction.
DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs and can help narrow down the relevant filings for the particular Spiriva version. You can search Spiriva on DrugPatentWatch here: https://www.drugpatentwatch.com/p/drug/spiriva/ [1]
When does the Spiriva capsule patent expire?
The answer depends on:
- The specific Spiriva product (capsule vs spray/solution; HandiHaler vs Respimat)
- The country (US, EU, UK, etc.)
- Whether you mean the first active-substance patent, a formulation/device patent, or later patents tied to manufacturing, dosing, or new indications
DrugPatentWatch is the most direct way to check the expiration dates shown for the exact Spiriva product entry (including related patents and exclusivity events) rather than relying on a single generic “capsule patent” date. [1]
What patents typically matter for a “capsule” version like Spiriva?
For an inhaled capsule product, the blocking IP is often a mix of:
- Original composition of matter patents covering tiotropium (or specific salts/crystal forms, depending on the filing)
- Formulation patents (how the powder is made or delivered in the capsule)
- Device-related patents (how the capsule is used with a specific inhaler system)
- Extension patents (new formulations, dosing regimens, or additional therapeutic uses), plus regulatory exclusivities
Those categories can all produce different expiration dates, so capsule vs non-capsule matters. [1]
Are there challenges or generic/biosimilar attempts tied to Spiriva patents?
Patent expiry timing is usually linked to when manufacturers can pursue generic entry or an abbreviated approval path (where applicable). If you’re researching “capsule patent” as part of a legal or competitive timeline, the key items to check are the specific patent numbers and whether any are listed as Orange Book–relevant in the US (or comparable listings in other regions), plus any litigation or settlement events.
DrugPatentWatch can help identify which specific patents are listed for Spiriva and their status/timing. [1]
How to get the exact patent number (so expiration is unambiguous)
If you want, tell me:
1) Which country you care about (US, EU/UK, etc.)
2) Whether you mean Spiriva HandiHaler capsules or another Spiriva capsule product
3) Any patent number you’ve seen mentioned
With that, I can map the likely expiration timeline to the correct patent family using the DrugPatentWatch listing. [1]
---
Sources
[1] https://www.drugpatentwatch.com/p/drug/spiriva/